VEON (NASDAQ:VEON) was upgraded by research analysts at TheStreet from a “d+” rating to a “c-” rating in a research report issued on Thursday, TheStreetRatingsTable reports.
Other analysts have also recently issued research reports about the stock. Goldman Sachs Group raised shares of Altria Group from a “neutral” rating to a “buy” rating and set a $59.00 price target on the stock in a research report on Thursday. BidaskClub cut shares of Vertex Pharmaceuticals from a “buy” rating to a “hold” rating in a research report on Tuesday. Bank of America reissued a “buy” rating and set a $43.00 price target (up previously from $36.00) on shares of The Medicines in a research report on Tuesday. Zacks Investment Research raised shares of SCHNEIDER ELEC /ADR from a “hold” rating to a “buy” rating and set a $20.00 price target on the stock in a research report on Friday, July 5th. Finally, ValuEngine cut shares of Zynerba Pharmaceuticals from a “buy” rating to a “hold” rating in a research report on Tuesday, May 28th. One research analyst has rated the stock with a hold rating and seven have given a buy rating to the company’s stock. The company has a consensus rating of “Buy” and an average target price of $3.19.
Shares of VEON traded down $0.03 during mid-day trading on Thursday, hitting $3.17. 3,871,004 shares of the company’s stock were exchanged, compared to its average volume of 8,837,672. The company has a market capitalization of $5.62 billion, a P/E ratio of -13.78 and a beta of 1.81. VEON has a fifty-two week low of $2.07 and a fifty-two week high of $3.28. The company has a 50-day moving average of $2.61.
Large investors have recently modified their holdings of the stock. Paloma Partners Management Co acquired a new stake in VEON in the fourth quarter valued at approximately $30,000. Squarepoint Ops LLC acquired a new stake in VEON in the fourth quarter valued at approximately $42,000. Arete Wealth Advisors LLC acquired a new stake in VEON in the fourth quarter valued at approximately $47,000. Evergreen Capital Management LLC acquired a new stake in VEON in the first quarter valued at approximately $62,000. Finally, Connor Clark & Lunn Investment Management Ltd. acquired a new stake in VEON in the fourth quarter valued at approximately $63,000. 16.22% of the stock is currently owned by hedge funds and other institutional investors.
VEON Company Profile
VEON Ltd., through its subsidiaries, provides mobile and fixed-line telecommunications services. It offers voice and data telecommunication services through a range of mobile and fixed-line technologies. The company provides value added services, including short messages, multimedia messages, caller number identification, call waiting, data transmission, mobile internet, downloadable content, mobile finance services, machine-to-machine, and other services; national and international roaming services; wireless Internet access and mobile financial services; and mobile bundles and call completion services.
Recommended Story: What are the advantages to having securities held in street name?
Receive News & Ratings for VEON Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for VEON and related companies with MarketBeat.com's FREE daily email newsletter.